Prognostic value of chemotherapy-induced neutropenia at the first cycle in invasive breast cancer
Open accessAbstract
Chemotherapy-induced neutropenia (CIN) was the most apparent side effects of bone marrow suppression with adjuvant chemotherapy. Recently, several studies revealed that CIN may predict better outcomes. However, the researches upon breast cancer were still indefinite. We reviewed the female patients with pathologically diagnosed invasive breast cancer at the First Affiliated Hospital of Wenzhou Medical University, between Jan 2008 and Dec 2010. The lowest neutrophil counts in the second week after the first cycle of chemotherapy were collected. Clinicopathological characteristics and survival rates were compared and analyzed between the CIN group and non-CIN group. The median follow-up time was 62 months. The differences of over-all survival and local recurrence-free survival between the 2 groups were nonsense (P = 0.938, P = 0.695, respectively). But the disease-free survival and distant metastasis-free survival of the CIN group were statically significantly better (HR = 0.391, P = 0.009, and HR = 0.315, P = 0.005, respectively). The bone metastasis-free survival may be responsible for the differences (HR = 0.469, P = 0.005). Subgroup analyses showed the CIN may predict lower bone metastases rates with ER positive status, premenopause or younger age (≤ 40) (P = 0.002, P = 0.004, and P = 0.0001, respectively). Cox analysis showed younger ages, N staging, and the presence of CIN were associated with bone metastasis-free survival independently adjusting to peritumoral vascular invasion (P < 0.05). CIN may predict a decreased recurrence risk of breast cancer, especially bone metastases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Chemotherapy-induced neutropenia has predicted improved survival rates among cancer patients.
“chemotherapy induced neutropenia has also predicted improved survival rates among cancer patients [12–17]”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766 · see citing works
Siegel, R. L., Miller, K. D., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21254 · Cited by 11,854 · see citing works
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Käkönen, S.-M., Cordon‐Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,562 · see citing works
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2012) · The Lancet · doi:10.1016/s0140-6736(11)61625-5 · Cited by 2,091 · see citing works
A Pooled Analysis of Bone Marrow Micrometastasis in Breast Cancer
Braun, S., Vogl, F. D., Naume, B., Janni, W., Osborne, M. P., Coombes, R. C., Schlimok, G., Diel, I., Gerber, B., Gebauer, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050434 · Cited by 1,380 · see citing works
Chemotherapy‐induced neutropenia
Crawford, J., Dale, D. C., & Lyman, G. H. (2004) · Cancer · doi:10.1002/cncr.11882 · Cited by 887 · see citing works
Gnant, M., Mlineritsch, B., Stoeger, H., Luschin-Ebengreuth, G., Heck, D., Menzel, C., Jakesz, R., Seifert, M., Hubalek, M., Pristauz, G., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70122-x · Cited by 471 · see citing works
Partridge, A. H., Burstein, H. J., & Winer, E. P. (2001) · JNCI Monographs · doi:10.1093/oxfordjournals.jncimonographs.a003451 · Cited by 427 · see citing works
Azim, H. A., Michiels, S., Bedard, P. L., Singhal, S. K., Criscitiello, C., Ignatiadis, M., Haibe‐Kains, B., Piccart, M. J., Sotiriou, C. P., & Loi, S. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2599 · Cited by 400 · see citing works
Breast Cancer Metastasis to Bone: Mechanisms of Osteolysis and Implications for Therapy
Kozlow, W., & Guise, T. A. (2005) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-005-5399-8 · Cited by 338 · see citing works
Predicting individual risk of neutropenic complications in patients receiving cancer chemotherapy
Lyman, G. H., Kuderer, N. M., Crawford, J., Wolff, D. A., Culakova, E., Poniewierski, M. S., & Dale, D. C. (2010) · Cancer · doi:10.1002/cncr.25691 · Cited by 239 · see citing works
Mackey, J. R., Martín, M., Pieńkowski, T., Rolski, J., Guastalla, J., Sami, A., Glaspy, J. A., Juhos, É., Wardley, A. M., Fornander, T., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70525-9 · Cited by 224 · see citing works
Martín, M., Lluch, A. M., Seguí, M. Á., Ruíz, A., Ramos, M., Adrover, E., Rodríguez-Lescure, Á., Große, R., Calvo, L., Fernández‐Chacón, C., et al. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl135 · Cited by 203 · see citing works
Yong, M., Jensen, A. Ø., Jacobsen, J. B., Nørgaard, M., Fryzek, J. P., & Sørensen, H. T. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1475-5 · Cited by 186 · see citing works
Jensen, A. Ø., Jacobsen, J. B., Nørgaard, M., Yong, M., Fryzek, J. P., & Sørensen, H. T. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-29 · Cited by 168 · see citing works
Understanding the biology of triple-negative breast cancer
Criscitiello, C., Azim, H., Schouten, P. C., Linn, S., & Sotiriou, C. (2012) · Annals of Oncology · doi:10.1093/annonc/mds188 · Cited by 162 · see citing works
del Giglio, A., Eniu, A. E., Ganea-Motan, D. E., Топузов, Э. Э., & Lubenau, H. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-332 · Cited by 105 · see citing works
Mechanisms of breast cancer bone metastasis
Zhang, Y., Ma, B., & Fan, Q. (2009) · Cancer Letters · doi:10.1016/j.canlet.2009.11.003 · Cited by 91 · see citing works
[Reliability at the National Cancer Institute-Common Toxicity Criteria version 2.0].
Kaba, H., Fukuda, H., Yamamoto, S., & Ohashi, Y. (2004) · PubMed · Cited by 88 · see citing works
Kishida, Y., Kawahara, M., Teramukai, S., Kubota, K., Komuta, K., Minato, K., Mio, T., Fujita, Y., Yonei, T., Nakano, K., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605348 · Cited by 87 · see citing works
Prognostic value of chemotherapy-induced neutropenia in early-stage breast cancer
Han, Y., Yu, Z., Wen, S., Zhang, B., Cao, X., & Wang, X. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1799-1 · Cited by 69 · see citing works
Ribelles, N., Santonja, Á., Pajares, B., Llácer, C., & Alba, E. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2013.09.010 · Cited by 59 · see citing works
Quayle, L. A., Ottewell, P. D., & Holen, I. (2015) · Current Cancer Drug Targets · doi:10.2174/1568009615666150506092443 · Cited by 40 · see citing works
Pousa, A. L., Rifà, J., Tejerina, A., González-Larriba, J. L., Iglesias, C., Gasquet, J. A., & Carrato, A. (2010) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2009.01121.x · Cited by 39 · see citing works
Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients
Lin, Y., Yin, W., Yan, T., Zhou, L., Di, G., Wu, J., Shen, Z., Shao, Z., & Lu, J. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-342 · Cited by 37 · see citing works
Identification of estrogen-responsive genes involved in breast cancer metastases to the bone
Wang, J., Jarrett, J. C., Huang, C., Satcher, R. L., & Levenson, A. S. (2007) · Clinical & Experimental Metastasis · doi:10.1007/s10585-007-9078-6 · Cited by 32 · see citing works
Health state utilities for skeletal-related events secondary to bone metastases
Matza, L. S., Chung, K., Brunt, K. V., Brazier, J. E., Braun, A., Currie, B. M., Palsgrove, A. C., Davies, E. W., & Body, J. (2013) · The European Journal of Health Economics · doi:10.1007/s10198-012-0443-2 · Cited by 32 · see citing works
Rambach, L. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i6.1565 · Cited by 27 · see citing works
The Microenvironment Matters: Estrogen Deficiency Fuels Cancer Bone Metastases
Wright, L. E., & Guise, T. A. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0576 · Cited by 21 · see citing works
Chen, Z., Chen, W., Wang, J., Zhu, M., & Zhuang, Z. (2015) · Internal Medicine Journal · doi:10.1111/imj.12786 · Cited by 16 · see citing works
Kwon, W., Oh, T. H., Lee, J. W., & Park, S. C. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3443 · Cited by 15 · see citing works
Ishitobi, M., Komoike, Y., Motomura, K., Koyama, H., & Inaji, H. (2010) · Oncology · doi:10.1159/000313702 · Cited by 13 · see citing works
Hill, N., & Madarnas, Y. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1542-y · Cited by 8 · see citing works
Lindman, H., Åström, G., Ahlgren, J., Villman, K., BLOMQVIST, C. P., Nygren, P., & Bergh, J. C. S. (2006) · Acta Oncologica · doi:10.1080/02841860600871087 · Cited by 8 · see citing works
Flagged first, then by citations
1 of the 36 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Surendran, V., Rutledge, D., Colmon, R., & Chandrasekaran, A. (2021) · Biofabrication · doi:10.1088/1758-5090/abe1cf · Cited by 99 · see citing works
Current management of chemotherapy-induced neutropenia in adults: key points and new challenges
Ba, Y., Shi, Y., Jiang, W., Feng, J., Cheng, Y., Xiao, L., Zhang, Q., Qiu, W., Xu, B., Xu, R., et al. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2020.0069 · Cited by 97 · see citing works
Kasi, P. M., & Grothey, A. (2018) · Drugs · doi:10.1007/s40265-018-0909-3 · Cited by 80 · see citing works
Valdés-Ferrada, J., Muñoz‐Durango, N., Pérez‐Sepúlveda, A., Muñiz, S., Coronado-Arrázola, I., Francisco Acevedo, C., Soto, J. A., Bueno, S. M., Sanchez, C. G., & Kalergis, A. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01413 · Cited by 34 · see citing works
Zhang, B., Dong, J., Sun, P., Feng, C., & Liu, Y. (2017) · Medicine · doi:10.1097/md.0000000000007750 · Cited by 27 · see citing works
Neutrophil-to-lymphocyte ratio and platelet count as prognostic factors in ovarian malignancies
Nomelini, R. S., Chiovato, A. F. C., Abdulmassih, F. B. F., da Silva, R. D. C., Tavares‐Murta, B. M., & Murta, E. F. C. (2018) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_304_17 · Cited by 24 · see citing works
Wang, T., Wu, B., Hu, X., Liu, J., Zhang, T., Li, F., Sun, B., Cai, L., Li, X., Chen, Z., et al. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.04.10 · Cited by 20 · see citing works
Lu, W., Jia, D., An, S., Mu, M., Qiao, X., Liu, Y., Li, X., & Wang, D. (2017) · Scientific Reports · doi:10.1038/s41598-017-08970-3 · Cited by 19 · see citing works
Pasqua, L. G. D., Abdallah, M. M., Feletti, F., Vairetti, M., & Ferrigno, A. (2024) · Pharmaceuticals · doi:10.3390/ph17040484 · Cited by 12 · see citing works
Nanotechnology-mediated immunochemotherapy with Ingenol-3-Mebutate for Systematic Anti-tumor Effects
Yu, M., Zhao, M., Yu, R., Chu, S., Xu, J., Xia, M., & Wang, C. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.007 · Cited by 10 · see citing works
Hutajulu, S. H., Oktariani, S., Sunggoro, A. J., Bintoro, B. S., Astari, Y. K., Wiranata, J. A., Widodo, I., Ekowati, A., Hardianti, M. S., Taroeno‐Hariadi, K. W., et al. (2023) · ecancermedicalscience · doi:10.3332/ecancer.2023.1618 · Cited by 8 · see citing works
Tan, G. F., Goh, S., Chang, E. W. Y., Tan, Y. H., Chiang, J., Yang, V. S., Poon, E. Y. L., Somasundaram, N., Rashid, M. F. B. H., Tao, M., et al. (2023) · Hematology Reports · doi:10.3390/hematolrep15010012 · Cited by 7 · see citing works
Katolkar, U. N., & Surana, S. J. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037307940240606075208 · Cited by 5 · see citing works
Local management of neutropenic ulcer in a patient under breast cancer treatment
Cotomácio, C. C., Magliano, G. C., Alves, F. A., & Simões, A. (2020) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2020.101997 · Cited by 5 · see citing works
Fever and breast cancer: A critical review of the literature and possible underlying mechanisms
Mehran, S., Taravati, A., Baljani, E., Rasmi, Y., & Gholinejad, Z. (2021) · Breast Disease · doi:10.3233/bd-201001 · Cited by 4 · see citing works
Neutropenia Associada ao Tratamento do Câncer de Mama: Revisão Integrativa da Literatura
Conte, F. M., Sgnaolin, V., & Sgnaolin, V. (2019) · Revista Brasileira de Cancerologia · doi:10.32635/2176-9745.rbc.2019v65n3.307 · Cited by 4 · see citing works
Poikonen‐Saksela, P., Lindman, H., Sverrisdóttir, Á., Edlund, P., Villman, K., Tennvall-Nittby, L., Cold, S., Bechmann, T., Stenbygaard, L. E., Ejlertsen, B., et al. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1757149 · Cited by 4 · see citing works
Lee, J. W., Bae, J. S., Kim, J. H., Cho, H. W., Ju, H. Y., Yoo, K. H., Koo, H. H., Woo, S., Kim, S., & Sung, K. W. (2021) · Cancer Research and Treatment · doi:10.4143/crt.2021.010 · Cited by 3 · see citing works
Yuan, Y., Zhang, L., Zhang, Z., Qian, Y., & Teng, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2702 · Cited by 3 · see citing works
Saad, E. S. P., Oualla, K., Talibova, N., Gening, S., & YousefYousef, S. G. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-07421-8 · Cited by 1 · see citing works
Saad, E. S. P., Qualla, K., Talibova, N., Gening, S., & Yousef, S. Y. G. (2022) · Research Square · doi:10.21203/rs.3.rs-1789606/v1
Khamashta, N., Dalal, A., Alashwas, M., Hamdan, M., Al-Rimawi, F., & Sahoury, Y. (2026) · Cancer Research Communications · doi:10.1158/2767-9764.crc-25-0770
Jain, V., Jangle, S., Jain, S., Mandloi, V., & Sharma, H. (2026) · The Journal of Medical Sciences · doi:10.5005/jp-journals-10045-00493
- Authors
- Ma, R.-M., Chen, C.-Z., Zhang, W., You, J., Huang, D.-P., & Guo, G.-L.
- Affiliations
- First Affiliated Hospital of Wenzhou Medical University (CN)
- Corresponding author
- Guo, Gui-Long
- Venue
- Medicine
- Published
- 2016-03
- Volume
- 95
- Issue
- 13
- Pages
- e3240
- ISSN
- 0025-7974 (ISSN-L)
- PMC
- PMC4998558
- OpenAlex
- W2418334019
- Cited by
- 23
- References
- 36
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 2 · 2017: 2
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Keywords
- chemotherapy-induced neutropenia, invasive breast cancer, prognostic factors, adjuvant chemotherapy, bone metastasis-free survival, disease-free survival, distant metastasis, local recurrence, estrogen receptor status, age, N staging
- MeSH terms
- Adult, Age Factors, Aged, Breast Neoplasms, Female, Humans, Leukocyte Count, Middle Aged, Neoplasm Metastasis, Neoplasm Staging, Neutropenia, Prognosis, Chemotherapy, Adjuvant, Disease-Free Survival, Genes, erbB-2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
